HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

Plantibodies

Plantibodies

Plantibodies, also known as plant-derived antibodies, are an emerging class of biologics that are produced from plants. They are composed of recombinant protein fragments, which are generated from plant expression systems. Plantibodies have a number of advantages over traditional animal-sourced antibodies. They are cost-effective and easier to manufacture, as they do not require animal serum, and they are also less likely to cause adverse reactions in patients due to their low immunogenicity. Plantibodies are also highly stable and can be produced at high yields, making them an attractive alternative to traditional antibodies. Plantibodies have been studied for a variety of therapeutic and diagnostic applications, such as cancer immunotherapies, infectious disease diagnostics, and allergy treatments. In addition, they are also being developed for use in vaccines and crop protection, making them a versatile and promising tool for medical and agricultural research.

Committee Members
Speaker at GPB 2027 - Abdul Khalil Gardezi

Abdul Khalil Gardezi

Colegio de Posgraduados, Mexico
Speaker at GPB 2027 - K R Aneja

K R Aneja

Kurukshetra University, India
Speaker at GPB 2027 - Mary Cole

Mary Cole

The University of Melbourne, Australia
GPB 2027 Speakers
Aparna B Gunjal

Aparna B Gunjal

Dr. D.Y. Patil, Arts, Commerce and Science College, India
Anna Ponce

Anna Ponce

Bethune-Cookman University, United States
Hillary Jean Pierre

Hillary Jean Pierre

Department of Pharmaceutics, United States

Submit your abstract Today

WhatsApp